199
Participants
Start Date
April 21, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Tobemstomig
Participants will receive IV tobemstomig Q3W.
Tiragolumab
Participants will receive IV tiragolumab Q3W.
Pembrolizumab
Participants will receive IV pembrolizumab Q3W.
Axitinib
Participants will receive axitinib PO BID.
Sunshine Coast University Hospital, Birtinya
National Cancer Center, Goyang-si
Hospital Universitario Reina Sofia, Córdoba
Centre Francois Baclesse, Caen
Sibley Memorial Hospital, Washington D.C.
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II, Hamburg
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
CHU Besançon - Hôpital Jean Minjoz, Besançon
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Emory University, Atlanta
Medizinische Hochschule Hannover, Hanover
CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux
University of Alabama at Birmingham, Birmingham
SCRI Oncology Partners, Nashville
Vanderbilt University Medical Center, Nashville
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitari i Politecnic La Fe, Valencia
Chonnam National University Hwasun Hospital, Jeollanam-do
Centre Leon Berard, Lyon
Studienpraxis Urologie, Nürtingen
Klinikum rechts der Isar der TU München, München
Institut Sainte Catherine, Avignon
Universitätsklinikum Ulm, Ulm
UC Irvine Medical Center, Orange
Institut Gustave Roussy, Villejuif
Peking University First Hospital, Beijing
Beijing Cancer Hospital, Beijing
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing
Tianjin Cancer Hospital, Tianjin
UT Southwestern Medical Center, Dallas
"Universitätsklinikum Carl Gustav Carus", Dresden
Szpital Specjalistyczny Podkarpacki O?rodek Onkologiczny, Brzozów
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka, Bydgoszcz
Szpital Uniwersytecki w Krakowie, Oddzia? Kliniczny Kliniki Onkologii, Krakow
Szpital Kliniczny im. Heliodora ?wi?cickiego UM w Poznaniu, Późna
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Barts & London School of Med, London
Christie Hospital Nhs Trust, Manchester
Hoffmann-La Roche
INDUSTRY